Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Takashi Shimada

SHIMADZU Corporation 1-3 Kanda-Nishiki-cho, Chiyoda-ku, Tokyo101-8448
Japan
Publications

Multiplex LCMS Bioanalysis of Brentuximab Vedotin, Rituximab and Cetuximab towards Therapeutic Drug Monitoring Application by Combined Calibration Curve Using Fab-Selective Limited Proteolysis nSMOL

Background: Recently, monoclonal antibody (mAb) bioanalysis using mass spectrometry has begun to be recognized as useful technology for mAbs measurement other than ELISA. We have recently exploited a high-precision method for bioanalysis of monoclonal antibody (mAb) using mass spectrometry. The method is nano-surface and molecular-orientation limit... Read More»

Noriko Iwamoto, Megumi Takanashi, Akinobu Hamada and Takashi Shimada

Research Article: Clin Pharmacol Biopharm 2016, 5:164

DOI: 10.4172/2167-065X.1000164

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top